Daskalopoulos N T, Brillet A M, Caron J, Cottereau M J, Deniker P
Ann Med Psychol (Paris). 1976 Jul;2(2):279-85.
The progressive exhaustion of the psychotropic effect of T.R.H. clinical and neuroendocrinological study. The study of a complicated clinical case permitted us to use T.R.H. because of the ineffectiveness of other psychotropic agents the patient (male, aged 38) was given previously. A major and atypical depressive state with severe anorexia was lasting from several months. T.R.H. was administered 3 times per day (at 8 h. 11 h and 14 h) as an intravenous injection of 0.5 mg of T.R.H. lasting 1 min. (total dose per day: 1.5 mg). From the 1st to 7th day the patient showed a market improvement) in the depression symptoms, followed by a light degradation observed from the 7th to 10th day. During a third phase, he showed wild improvement which was maintened stable from the 10th to the 21st day. Then, there was a progressive return to the state prior to T.R.H. period till the 30th day. This phase lasted up to the end of the therapeutic trial of T.R.H. These fluctuations of the depressive state were not found to be correalted with significant plasma-T.R.H. changes and seem to happen when changes in catecholamines and/or serotonin were not observed, according to methods used. Independently of various theoritical approaches concerning the mechanism of psychotropic T.R.H. action, it seems that its effect is exhausted progressively and rapidly.
促甲状腺激素(TRH)精神otropic效应的渐进性消退:临床与神经内分泌学研究。对一例复杂临床病例的研究使我们能够使用TRH,因为此前给予该患者(38岁男性)的其他精神otropic药物均无效。一种伴有严重厌食的重度非典型抑郁状态已持续数月。TRH以每天3次(8时、11时和14时)静脉注射0.5mg的方式给药,每次注射持续1分钟(每日总剂量:1.5mg)。从第1天到第7天,患者的抑郁症状有明显改善,随后在第7天到第10天观察到轻度恶化。在第三阶段,他有显著改善,并从第10天到第21天保持稳定。然后,直到第30天,病情逐渐恢复到TRH治疗期之前的状态。这一阶段一直持续到TRH治疗试验结束。根据所使用的方法,未发现抑郁状态的这些波动与血浆TRH的显著变化相关,且似乎是在未观察到儿茶酚胺和/或血清素变化时发生的。不管关于精神otropic性TRH作用机制的各种理论方法如何,其效应似乎会逐渐且迅速地消退。